Treatment of Hypertension in Primary Care in Spain

An observational study of Hypertension, run by AstraZeneca at 167 sites in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Trial summary

Non-interventional,observational and retrospective study assessing the therapeutic and diagnostic attitude followed in primary care for a hypertensive patient depending on his degree of blood pressure control. Read more about this study

Who is it for?: Ages 18 years and older
Conditions the study is for: Hypertension
How many people: 2,160 participants
Where: 167 sitesSpain
Study dates: Mar 2009to Jul 2009
Phase: Observational
Are there results?: None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

Ages 18 years and older
All sexes
No healthy volunteers
Adult, Older adult

Study population: Patients aged 18 years or older who has been diagnosed of primary hypertension and/or treated for hypertension.

Who may be able to join

Diagnosis of primary hypertension and/or treated for hypertension for one year or more
Clinical data of blood pressure measures for the last 12+/- 2 months before inclusion.

Who cannot join

Secondary Hypertension
Physical or psychological impairment for the understanding of the information to be given to the patient

Trial locations and contacts

167 sites in 1 country.

City, postcode or hospital

167 sites in 1 country

Spain167 sites

Research Site
A Coruña
Research Site
Adeje
Research Site
Águilas
Research Site
Alacant / Alicante
Research Site
Alburquerque
Research Site
Alcalá de Henares
Research Site
Alcantarilla
Research Site
Alfajarín
Research Site
Algeciras
Research Site
Algimia de Alfara
Research Site
Almacelles
Research Site
Almería
Research Site
Andratx
Research Site
ARES (pontedeume)
Research Site
Arroyo de la Miel
Research Site
As Pontes de García Rodríguez
Research Site
Avilés
Research Site
Badajoz
Research Site
Barcelona
Research Site
Barreiros (casco Urbano)
Research Site
Belmonte
Research Site
Beniarjó
Research Site
Bilbao
Research Site
Boiro (boiro)
Research Site
Boqueixon (ponteulla)
Research Site
Burgos
Research Site
Burjassot
Research Site
Cadiz
Research Site
Calahorra
Research Site
Calamonte
Research Site
Calatayud
Research Site
Caldes de Montbui
Research Site
Campanario
Research Site
Carballo (carballo)
Research Site
Castalla
Research Site
Castellon
Research Site
Ceuta
Research Site
Cieza
Research Site
Corbera de Llobregat
Research Site
Córdoba
Research Site
Corme-Porto
Research Site
Cubells
Research Site
Cuenca
Research Site
Cullera
Research Site
Dacón
Research Site
Don Benito
Research Site
Dos Hermanas
Research Site
El Bonillo
Research Site
El Ejido
Research Site
el Pla del Penedès
Research Site
ELX / Elche
Research Site
Fraga
Research Site
Fraile
Research Site
Fuente del Arco
Research Site
Gáldar
Research Site
Gallarta
Research Site
Gallur
Research Site
Gandia
Research Site
Gavà
Research Site
Getafe
Research Site
Getxo
Research Site
Gijón
Research Site
Girona
Research Site
Godella
Research Site
Grado
Research Site
Granada
Research Site
Granollers
Research Site
Guía de Isora
Research Site
Higuera la Real
Research Site
Jerez de la Frontera
Research Site
La Línea de la Concepción
Research Site
La Orotava
Research Site
La Pesga
Research Site
Las Palmas de Gran Canaria
Research Site
Las Torres de Cotillas
Research Site
Leganés
Research Site
Legutio
Research Site
León
Research Site
Lestrobe
Research Site
Linyola
Research Site
Lora del Río
Research Site
Los Corrales de Buelna
Research Site
Los Realejos
Research Site
Los Yébenes
Research Site
Madrid
Research Site
Madroñera
Research Site
Málaga
Research Site
Manises
Research Site
Manresa
Research Site
Marmolejo
Research Site
Miranda de Ebro
Research Site
Mislata
Research Site
Mollet del Vallès
Research Site
Monforte del Cid
Research Site
Monistrol de Montserrat
Research Site
Monover/monovar
Research Site
Montilla
Research Site
Morata de Jalón
Research Site
Mutxamel
Research Site
Nava de la Asunción
Research Site
Navalperal de Pinares
Research Site
Noreña
Research Site
Olivenza
Research Site
Onil
Research Site
Palau-saverdera
Research Site
Palma de Mallorca
Research Site
Pamplona
Research Site
Parets del Vallès
Research Site
Petrel
Research Site
Pinto
Research Site
Pizarra
Research Site
Porreres
Research Site
Portals Nous
Research Site
Posada de Llanes
Research Site
Pozo-Cañada
Research Site
Puerto Lumbreras
Research Site
Purias
Research Site
Quart de Poblet
Research Site
Quintana de la Serena
Research Site
Quiroga (casco Urbano)
Research Site
Roturas
Research Site
Sabadell
Research Site
San Martín de Luiña
Research Site
San Vicente de Alcántara
Research Site
Sant Carles de la Ràpita
Research Site
Sant Cugat Sesgarrigues
Research Site
Sant Feliu de Llobregat
Research Site
Sant Martí Sarroca
Research Site
Santa Coloma de Gramenet
Research Site
Santander
Research Site
Segorbe
Research Site
Serradilla
Research Site
Seville
Research Site
Son Ferriol
Research Site
Soto de la Marina
Research Site
Taboadela
Research Site
Tauste
Research Site
Toledo
Research Site
Tordesillas
Research Site
Torre de Don Miguel
Research Site
Torredelcampo
Research Site
Torrejón de Ardoz
Research Site
Torrejoncillo
Research Site
Torrellano
Research Site
Torres de Segre
Research Site
Torrevieja
Research Site
Trapagaran
Research Site
Tui
Research Site
Utrillas
Research Site
Valencia
Research Site
Valencia de Alcántara
Research Site
Valladolid
Research Site
Vallirana
Research Site
Vigo
Research Site
Viladecans
Research Site
Vilanova (lourenza)
Research Site
Villafranca de los Barros
Research Site
Villagonzalo-Pedernales
Research Site
Villalba de los Barros
Research Site
Vitoria-Gasteiz
Research Site
Xàtiva
Research Site
Xinzo de Limia
Research Site
Yecla
Research Site
Zafra
Research Site
Zalamea de la Serena
Research Site
Zamora
Research Site
Zaragoza

Other trials in Spain

About this study

Conditions: Hypertension
Keywords: Hypertension, Therapeutic diagnostic attitude, Blood pressure
Medical subject headings: Hypertension

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT00868881
Study group	Role	What they receive
1		Blood Pressure poorly controlled in the previous year and poorly controlled at the inclusion in the study
2		Blood Pressure poorly controlled in the previous year and well controlled at the inclusion in the study.
3		Blood Pressure well controlled in the previous year and well controlled at the inclusion in the study
4		Blood Pressure well controlled in the previous year and poorly controlled at the inclusion in the study
5		Blood Pressure well controlled in the previous year independently of the level of control at the inclusion.
6		Blood Pressure poorly controlled in the previous year independently of the level of control at the inclusion.

What is being measured

The primary outcome is the main question the study is designed to answer.

Therapeutic and diagnostic attitude followed in primary care for a hypertensive patient depending on his degree of blood pressure control.
Measured: 1 Year

Secondary outcomes (2)

Variation in the Percentage of patients with blood pressure controlled and not controlled during a year of follow-up.
Measured: 1 Year
Clinical profile and cardiovascular risk.
Measured: 1 Year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

Mar 2009Jul 2009

First posted25 Mar 2009 (estimated)
Study startMar 2009
Study completionJul 2009

Resources

Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
Other trials for HypertensionStudies of the same condition, open and under way.
More trials run by AstraZenecaThe sponsor's other registered studies.
What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design

Study type: Observational
Time perspective: Retrospective
Enrolment: 2,160 participants (estimated)

IDs, dates and publications

ClinicalTrials.gov ID: NCT00868881
Sponsor's protocol ID: NIS-CES-DUM-2008/2
Acronym: TAPAS
Status last verified: Jul 2009
First submitted: 24 Mar 2009
Last updated: 13 Jul 2009
Results posted: No
Data monitoring committee: No

Want to know more?

The sponsor has not listed a contact. The official record may have more details.

Talk to your doctor first and take this page with you. Only the study team can confirm whether you can join.

Questions to ask the study team

What is the study trying to find out?
What would I need to do, and how often would I visit?
Could I receive a placebo instead of the treatment?
What are the possible risks and benefits for me?
Will it cost me anything? Are travel or time paid for?
Can I keep seeing my own doctor during the study?
What happens when the study ends?

See locations

Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
Recruiting
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
Chronic Kidney Disease, Hypertension (HTN)
Recruiting
Trial Phase: Syndemic Adapted Medly Uganda
Mental Health
Not yet recruitingPhase 2/3
An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)
Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease
Enrolling by invitation
Testing Implementation Strategies to Support Clinic Fidelity to an Outpatient Hypertension Bundle
Pregnancy Related, Hypertension

All Hypertension trials

Study at a glance

From the registry record, last updated by the sponsor on 13 Jul 2009. Recruitment status is as the sponsor reported it: confirm with the study team.

Official title: Treatment of Hypertension in Primary Care in Spain
ClinicalTrials.gov ID: NCT00868881
Acronym / sponsor ID: TAPAS / NIS-CES-DUM-2008/2
Conditions: Hypertension
Keywords: Hypertension, Therapeutic diagnostic attitude, Blood pressure
Study type: Observational
Recruitment status: Completed
Enrolment: 2,160 participants (estimated)
Lead sponsor: AstraZenecaIndustry (pharma, biotech, devices)
Study start: Mar 2009
Study completion: Jul 2009 (actual)
First posted: 25 Mar 2009 (estimated)
Results: Not posted in the source record

Clinical summary

The research question as the sponsor registered it. This describes what the study plans to test, not what it found.

Study design

Time perspective: Retrospective
Number of arms: 6

Arm	Type	Receives
1	–	–Blood Pressure poorly controlled in the previous year and poorly controlled at the inclusion in the study
2	–	–Blood Pressure poorly controlled in the previous year and well controlled at the inclusion in the study.
3	–	–Blood Pressure well controlled in the previous year and well controlled at the inclusion in the study
4	–	–Blood Pressure well controlled in the previous year and poorly controlled at the inclusion in the study
5	–	–Blood Pressure well controlled in the previous year independently of the level of control at the inclusion.
6	–	–Blood Pressure poorly controlled in the previous year independently of the level of control at the inclusion.

Who may qualify

Ages: 18 years and older
Sex: All
Healthy volunteers: Not accepted
Age groups: Adult, Older adult
Study population: Patients aged 18 years or older who has been diagnosed of primary hypertension and/or treated for hypertension.

Key inclusion criteria (2 listed)

Diagnosis of primary hypertension and/or treated for hypertension for one year or more
Clinical data of blood pressure measures for the last 12+/- 2 months before inclusion.

Key exclusion criteria (2 listed)

Secondary Hypertension
Physical or psychological impairment for the understanding of the information to be given to the patient

Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.

Primary outcome

Therapeutic and diagnostic attitude followed in primary care for a hypertensive patient depending on his degree of blood pressure control.
Time frame: 1 Year

2 secondary outcomes

Variation in the Percentage of patients with blood pressure controlled and not controlled during a year of follow-up.
Time frame: 1 Year
Clinical profile and cardiovascular risk.
Time frame: 1 Year

Results and safety

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

Research links

Official record on ClinicalTrials.govLast updated by the sponsor 13 Jul 2009.

Related trials for Hypertension

Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
Recruiting
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
Chronic Kidney Disease, Hypertension (HTN)
Recruiting
Trial Phase: Syndemic Adapted Medly Uganda
Mental Health
Not yet recruitingPhase 2/3
An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)
Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease
Enrolling by invitation
Testing Implementation Strategies to Support Clinic Fidelity to an Outpatient Hypertension Bundle
Pregnancy Related, Hypertension

Referral and contact

AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.

The record lists no contact. Use the official record to reach the sponsor.

167 sites in 1 country: see every site and its status.

Questions about this trial

What is this clinical trial studying?

An observational study of Hypertension, run by AstraZeneca at 167 sites in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Jul 2009. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 167 sites in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Therapeutic and diagnostic attitude followed in primary care for a hypertensive patient depending on his degree of blood pressure control. (time frame: 1 Year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00868881.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jul 2009.